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A Murray Valley encephalitis virus (MVE) field isolate of high neuroinvasiveness (BH3479) and a neutralization escape
variant of low neuroinvasiveness (BHv1) selected from BH3479 (which differ by a single amino acid at residue 277 in the
envelope glycoprotein) were examined for their distribution in the tissues of weanling Swiss mice at various times after
footpad inoculation. BH3479 was first detected in lymph nodes draining the inoculated limb at 24 hr postinoculation (pi)
and was found in serum between 36 and 72 hr pi. BH3479 was first detected in the central nervous system (CNS) at 4
days pi and reached maximum CNS titers (109 PFU/g) between 6 and 9 days pi. All BH3479-infected mice developed
encephalitis and died before 10 days pi. In contrast, BHv1 was not detected in lymph nodes draining the footpad at any
time after inoculation; BHv1 was first detected in the serum between 60 and 72 hr pi— 24 hr later, and at a 20-fold lower
titer than for BH3479. BHv1 was first detected in the CNS at 7 days pi 3 days later and at a 300-fold lower titer than for
BH3479. After 10 days pi, BHv1 could not be isolated from the CNS or from other host tissues. Most BHv1-infected mice
experienced a subclinical infection; the mortality rate from BHv1 infection was less than 1%. Both viruses appeared to enter
the CNS via the olfactory lobes. BH3479 spread throughout the CNS in a rostral to caudal direction over 3– 4 days. In
contrast, BHv1 infection in the CNS was restricted to the olfactory lobes and adjacent structures of the forebrain. q 1996
Academic Press, Inc.
INTRODUCTION several attenuated strains derived from it by cell culture
passage have shown that a relatively small number of
Murray Valley encephalitis virus (MVE) is a member attenuating amino acid changes (mostly in E) are se-
of the flavivirus genus of the Flaviviridae, a group of small, lected during serial passage (Nitayaphan et al., 1990; Ni
lipid enveloped plus-stranded RNA viruses, most of et al., 1995). Reduction in neuroinvasiveness has been
which are transmitted to vertebrate hosts by invertebrate associated with single amino acid changes in the E pro-
vectors. Arthropod-borne flaviviruses are the causative tein of MVE cell passage variants (Lobigs et al., 1990;
agents of a number of clinically significant human dis- McMinn et al., 1995b) and of JE (Cecilia and Gould, 1991;
eases including yellow fever, dengue fever, Japanese Hasegawa et al., 1992) and MVE (McMinn et al., 1995a)
encephalitis, St. Louis encephalitis, and Murray Valley neutralization (N) escape variants. However, these stud-
encephalitis. Flaviviruses have been grouped into eight ies do not provide insight into mechanisms of attenuation
antigenic complexes on the basis of cross-reactivity in associated with mutations in E.
neutralization assays (Calisher et al., 1989); MVE is a MVE causes an age-dependent encephalitis in mice
member of the Japanese encephalitis virus (JE) serocom- after peripheral inoculation (MacDonald, 1952a), and this
plex, a group of antigenically and genotypically related disease provides a good animal model of arbovirus-me-
viruses which are mosquito-transmitted and encephalito- diated encephalitis in humans (see Monath, 1986). Mac-
genic in humans. Donald (1952b) showed that intramuscular inoculation of
An understanding of the molecular genetics of viru- the highly passaged prototype virus MVE-1-51 (French,
lence is essential for the development of defined, live 1952) into 1-week-old outbred mice resulted in the simul-
attenuated flavivirus vaccines from infectious cDNA taneous appearance of infectious virus at the inoculation
clones. Several studies have pointed to the importance site and in the bloodstream between 2 and 4 days postin-
of the envelope (E) glycoprotein in flavivirus virulence. oculation (pi), followed by infection in the central nervous
Examination of the nucleotide and deduced amino acid system (CNS) between 3 and 5 days pi. Although this
sequence differences between a virulent strain of JE and study demonstrated spread of MVE from the bloodstream
to the CNS, definitive evidence of virus replication in
peripheral tissues prior to viremia (i.e., between 24 and1 To whom reprint requests should be addressed at current address:
48 hr pi) was not reported, probably due to insensitivityDepartment of Microbiology, The University of Western Australia,
of the virus titration method used. Thus, target tissuesQueen Elizabeth II Medical Centre, Nedlands, W.A. 6009, Australia.
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The means by which encephalitogenic flaviviruses Plaque assay
cross the blood – brain barrier and gain entry into the
Virus was assayed by plaque formation on Vero cellCNS have been debated for many years (see Johnson,
monolayers grown in six-well plastic trays (tissue culture1982) and are currently unresolved. Possible mecha-
grade; Linbro Scientific Inc.). Monolayers were stainednisms include (1) passive diffusion or transcytosis of vi-
at 2 days pi with 1 ml of agar stain (0.5% agar, 0.02%rus particles across cerebral capillary endothelial cells
neutral red in water) and plaques were counted afteror (2) replication of virus in endothelial cells followed by
overnight incubation. Infectivity titers are expressed asbudding of virus on the parenchymal side. Alternatively,
plaque-forming units (PFU) per milliliter.virus may bypass the blood– brain barrier by invading
the olfactory epithelium followed by infection of olfactory
Virulence assay
neurons and entry into the CNS. Previous animal studies
indicate that different flaviviruses may enter the CNS by Virulence was assayed by a modification of the method
different routes. Mims (1957) isolated yellow fever virus of Monath et al. (1980). Groups of five 21-day-old Swiss
from both the anterior and posterior parts of the murine outbred mice were inoculated into the right hind footpad
CNS at the same time after peripheral inoculation, sug- (fp) with 10-fold dilutions of virus (in HBSS), from 1001 to
gesting hematogenous spread. In contrast, Monath et al. 1009. Mice were examined daily for 17 days for signs of
(1983) established that St. Louis encephalitis virus (SLE) illness and deaths recorded. Fifty percent lethal doses
infected the olfactory epithelium of peripherally inocu- (LD50s) were calculated by the method of Reed and
lated hamsters and then passed via olfactory nerve fibers Muench (1938). All experiments were in accordance with
to the olfactory lobes of the CNS. the guidelines of the Australian National University Ani-
We previously selected a N-escape variant (BHv1) from mal Ethics Committee. Footpad inoculation was used to
the low-passage MVE field isolate BH3479 (Marshall et permit an examination of virus presence in regional
al, 1982). BHv1 is of low neuroinvasiveness in mice lymph nodes in the tissue distribution studies. Lymph
(McMinn et al., 1995a) and differs from neuroinvasive nodes which drain the lower limb (popliteal, paraaortic)
BH3479 by a single nucleotide in the E gene which re- are easier to identify and dissect than are lymph nodes
sults in substitution of a single amino acid at position E- which drain the peritoneal space (Malkova and Frankova,
277 (Ser r Ile). In this communication we report a study 1959).
of the pathogenesis of MVE-mediated encephalitis in
Virus growth in mouse tissuesweanling mice after peripheral inoculation, with the aim
of determining whether differences in the spread of MVE
Groups of fifty 21-day-old Swiss mice were inoculatedfrom the inoculation site could account for the observed
with 100 PFU of virus into the right hind footpad. At thedifferences in neuroinvasiveness. Spread of BH3479 and
indicated times after inoculation, 3 mice from each groupBHv1 in the tissues of Swiss mice after footpad inocula-
were anesthetized and killed by exsanguination through
tion was examined by plaque titration of infectious virus
intracardiac puncture. Tissues were collected, individu-
in tissue homogenates. Serum antibody responses to
ally weighed, snap frozen on dry ice, and stored at
MVE infection were assayed by enzyme-linked immuno- 0807C. They were subsequently dispersed in Dounce
sorbent assay (ELISA). Spread of BH3479 and BHv1 in
homogenizers and prepared as 1 or 10% suspensions in
the murine CNS was examined by in situ hybridization.
HBSS containing 2% bovine serum albumin. Virus was
titrated by plaque formation on Vero cell monolayers. The
MATERIALS AND METHODS
threshold for detection of virus in 1% tissue suspensions
Virus strains and cells was 500 PFU/g; the threshold for 10% suspensions
was 50 PFU/ml or g.The MVE field isolate BH3479 was isolated from a pool
of Culex annulirostris mosquitoes and passaged once in Assay of antibody in mouse sera
suckling mouse brain (smb; Marshall et al., 1982). The
N-escape variant BHv1 was selected from BH3479 in the Ninety-six-well microtiter plates (Costar) were coated
for 2 hr at 377C with polyethylene glycol-concentratedpresence of the MVE-specific, neutralizing monoclonal
antibody (mAb) 4B6C-2 (Hawkes et al., 1988) as pre- MVE antigen diluted to 106 PFU/ml in borate-buffered
saline (pH 9.0). Plates were rinsed with phosphate-buff-viously described (McMinn et al., 1995a). Working stocks
were Vero cell supernatants diluted in Hanks’ balanced ered saline, pH 7.4 (PBS), containing 5% nonfat milk pow-
der and incubated for 2 hr at 377C with serial twofoldsalt solution, pH 8.0 (HBSS).
African green monkey kidney (Vero) cells (ATCC, CCL dilutions of the mouse sera to be tested. After rinsing
(16) with PBS containing 0.05% Tween 20, bound anti-81) were grown at 377C in 5% CO2/95% air in Eagle’s
minimal essential medium (EMEM) supplemented with bodies were detected with goat anti-mouse IgG or goat
anti-mouse IgM conjugated to horseradish peroxidase5% fetal calf serum. Vero cells were used between pas-
sage levels 122 and 137. (Silenus), diluted in PBS– 5% milk powder (1:50) for 30
AID VY 7958 / 6a18$$$121 05-28-96 14:03:31 vira AP: Virology
416 MCMINN, DALGARNO, AND WEIR
min at room temperature. Color development was with ers and Gerfin-Moser (1993). The DIG-labeled cRNA was
hydrolyzed by adding 115 ml of solution A (5 ml 1 M DTT,1 mg/ml of 2,2*-azinobis(3-ethylbenzthiazoline) sulfonic
acid (ABTS; Sigma) in citrate – phosphate buffer (61 mM 40 ml 1 M NaHCO3 , 60 ml 1 M Na2CO3, 395 ml water) and
incubating at 607C for 45 min. Hydrolysis was stopped bycitric acid, 77 mM Na2HPO4, pH 4.0) with 0.003% H2O2.
Optical density (OD) was measured at 410 nm using chilling on ice and neutralizing with 115 ml of solution B
(5 ml 1 M DTT, 5 ml acetic acid, 100 ml 1 M sodiuman automated plate reader (Dynatech). End points were
defined as the highest serum dilutions which gave OD acetate, 390 ml water). RNA fragments were precipitated
with 1/10 vol of 4 M LiCl and 2.5 vol of ethanol at 0807Creadings of greater than 0.1 (10-fold greater than nega-
tive control values); controls included nonimmune mouse for 1 hr. The precipitated RNA fragments were resus-
pended in 10 ml DEPC– water.ascitic fluid and preimmune mouse sera which typically
gave OD values of less than 0.01.
Preparation of frozen tissue sections
Preparation of digoxigenin-labeled cRNA The brains and vertebral column sections of anesthe-
tized Swiss mice were dissected, covered in Cryo-M-Bed
MVE cDNA cloned into pMT21 and encompassing 5.4
(Bright Instruments) embedding medium, snap frozen in
kb of the 5* region of the MVE genome (Dalgarno et al., acetone– dry ice (1:1), and immediately stored at 0807C
1986) was digested with PstI and SacI (New England for up to several weeks. Sagittal sections of the brain
Biolabs) for 2 hr at 377C, to yield a 558-nucleotide cDNA blocks (15 mm) and transverse sections of the vertebral
fragment encompassing the 3* end of the MVE E gene
column blocks (10 mm) were cut on a cryostat and
(nucleotides 1948– 2506). The cDNA fragment was puri-
mounted onto slides which had been precoated with 3-
fied by electrophoresis in 1% low-melting-temperature
aminopropyltriethoxy silane (ICN Biochemicals). Sec-
agarose gel (FMC BioProducts), extracted twice with
tions were air-dried at room temperature (RT) for 30 min,
phenol/chloroform, and precipitated with a 1/10 vol of 3
fixed in phosphate-buffered 4% paraformaldehyde for 20
M sodium acetate (pH 5.2) and 2.5 vol of ethanol for at
min, washed three times in PBS, and stored at 47C in
least 1 hr at 0807C. After centrifugation, the DNA pellet
70% ethanol/30% DEPC-treated water. Adjacent sagittal
was washed in 70% ethanol and resuspended in distilled
sections were stained with cresyl fast violet or by in
water. The cDNA was subcloned into the polylinker site
situ hybridization. The cresyl fast violet-stained tissue
of the transcription vector pGEM-4Z (Promega). To gener- sections were used to locate specific neuroanatomical
ate runoff transcripts, the recombinant plasmid was lin- structures by reference to a stereotaxic atlas of the
earized with HindIII (New England Biolabs) for 2 hr at mouse brain (Slotnick and Leonard, 1975).
377C, followed by treatment with RNAse A (10 mg/ml;
Pharmacia) for 10 min at 377C and digestion with protein- In situ hybridization
ase K (10 mg/ml; Boehringer-Mannheim) for 30 min at
377C. The linearized plasmid DNA was extracted twice Tissue sections were treated with 0.2 N HCl for 20 min
at RT, acetylated for 10 min in 0.25% acetic anhydridewith phenol/chloroform and precipitated with 3 M sodium
acetate (pH 5.2) and 2.5 vol of ethanol. After centrifuga- (Mallinckrodt Australia) containing 0.1 M triethanolamine
(Ajax Chemicals), and washed three times in PBS. Prehy-tion, the pellet was washed in 70% ethanol and dissolved
in diethyl pyrocarbonate (DEPC)-treated water at a con- bridization was at RT for 2– 3 hr in 200 ml hybridization
buffer [50% formamide; 21 SSC (0.15 M NaCl, 0.015 Mcentration of 200 ng/ml.
Transcription reactions (50 ml) consisted of 22 ml sodium citrate); 0.01 M Tris – HCl; 12.5% Denhardt’s solu-
tion (0.02% Ficoll, 0.02% bovine serum albumin, 0.02%DEPC– H2O, 4 ml linearized cDNA (1 mg), 10 ml 51 tran-
scription buffer (Promega), 5 ml NTP mix (10 mM ATP, polyvinylpyrrolidone); 0.1% Triton X-100; 250 mg/ml
sheared, denatured salmon sperm DNA; 5 mg/ml sodiumCTP, GTP, 6.5 mM UTP, 3.5 mM digoxigenin– UTP; Boeh-
ringer-Mannheim), 5 ml 0.1 M dithiothreitol (DTT; Pro- pyrophosphate]. Hybridization solution was prepared by
addition of 200 ng DIG-cRNA per milliliter of hybridizationmega), 1.2 ml RNAse inhibitor (38 U/ml, Promega), and 3
ml SP6 RNA polymerase (20 U/ml, Promega). The reaction buffer, heated for 5 min at 857C to denature the probe,
and chilled on ice. Prehybridization solution was re-was incubated for 2 hr and stopped by degrading the
cDNA with 10 ml DNAse (RNAse-free, 1 U/ml, Promega) moved by suction and 100 ml of hybridization mixture
was added to the sections, which were then coveredfor 15 min at 377C. Typically, 1 mg of linearized cDNA
template yielded15 to 20 mg of DIG-labeled cRNA. The with a siliconized coverslip. Hybridization was carried
out in a humidified chamber at 377C for 18– 20 hr. AftercRNA derived by SP6 polymerase in vitro transcription
was of negative polarity and thus hybridizes with positive hybridization, the coverslips were removed by immersion
in 41 SSC and the sections washed twice in 21 SSCsense (genomic) MVE RNA.
To reduce the probe length to 150 – 200 nucleotides for 15 min at RT. The sections were incubated for 30 min
with RNAse A (10 mg/ml in 21 SSC) to digest unboundfor in situ hybridization, the cRNA transcripts were
treated by alkaline hydrolysis following Schaeren-Wiem- probe and washed twice in 0.11 SSC for 20 min at 377C,
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once in 0.11 SSC for 15 min at RT, and once in digoxi- virus titration at 12-hr intervals until 3 days pi, at daily
intervals from 4 to 14 days pi, and at weekly intervalsgenin buffer 1 (‘‘B1’’; 0.1 M Tris– HCl, pH 7.5; 0.15 M NaCl)
for 5 min at RT. between 2 and 8 weeks pi. Infectious virus was detected
in the following tissues: footpad, serum, spleen, skeletal
Immunological detection of DIG-labeled hybrids muscle, brain (detection threshold 50 PFU/ml or g), and
lymph nodes (threshold 500 PFU/g). No virus infectivityTissue sections were incubated in B1 containing 0.5%
was detected at any time after inoculation in lung, liver,(w/v) ‘‘Blocking Reagent’’ (‘‘B2’’; Boehringer-Mannheim) at
kidney, thymus gland (threshold 50 PFU/g), and adrenalRT for 30 min and then incubated in B2 containing anti-
gland (threshold 500 PFU/g). It is possible that extraneu-DIG polyclonal antiserum/alkaline phosphatase conju-
ral tissues which were not examined in this study alsogate (1:500) (Boehringer-Mannheim) for 1 hr. Tissue sec-
supported MVE replication.tions were then washed twice in B1 for 15 min and once
Tissue distribution of BH3479. After inoculation of thein buffer 3 (‘‘B3’’; 0.1 M Tris – HCl; 0.1 M NaCl; 5 mM
right hind footpad, BH3479 was first isolated from theMgCl2 , pH 9.5) for 5 min. Visualization of the signal was right popliteal lymph node at 24 hr pi (4 1 104 PFU/g)effected by incubation of the sections in 100 ml of sub-
(Fig. 1A); this titer represents a 100-fold increase in thestrate buffer (‘‘B4’’) containing 4.5 ml of 4-nitroblue tetrazo-
total number of PFU over the inoculum. Virus was notlium chloride (NBT; 100 mg/ml in 70% dimethyl for-
detected in any tissues at 12 hr pi. The lymph node titermamide; Boehringer-Mannheim), 3.5 ml of X-phosphate
was 105 PFU/g at 48 hr pi and remained at similar(5-bromo-4-chloro-3-indolyl phosphate, 50 mg/ml; Boeh-
levels throughout the remaining life of the mice. Viremiaringer-Mannheim), and 0.24 mg levamisole per 1 ml of
was first detected between 24 and 36 hr pi, peaked atB3. The tissue sections were incubated in B4 for 8 to 10
48– 60 hr pi (2 1 105 PFU/ml), fell gradually, and washr in the dark, until the desired staining intensity was
undetectable by 7 days pi. In contrast, popliteal lymphreached. Sections were washed several times in distilled
nodes from the uninoculated limb were infected by hema-water, lightly counterstained with hematoxylin, and
togenous spread. Virus was first isolated from thesemounted in Crystal-Mount (Biomeda).
lymph nodes at 3 days pi (following the viremia) and was
present throughout the life of the mice at titers similar
RESULTS
to those found in lymph nodes draining the inoculated
(right) hind limb. Virus appeared in both the inoculatedNeuroinvasiveness of BH3479 and BHv1 after
and uninoculated footpads at 3 days pi (2 1 103 PFU/g),footpad inoculation
indicating hematogenous spread, and continued to be
To follow the spread of MVE from a peripheral site of isolated from these tissues until 9 days pi. Titers of
infection in the skin, studies were designed using foot- BH3479 in the footpad were almost identical to those
pad inoculation of 21-day-old Swiss mice to initiate infec- found in the gastrocnemius muscle of the left hind limb
tion. Virulence assays of BH3479 and BHv1 by intraperi- (5 1 103 PFU/g) (data not shown), suggesting that virus
toneal (ip) and intracerebral (ic) inoculation of 21-day-old detected in the footpads was replicating in skeletal mus-
Swiss mice have been reported previously (McMinn et cle and/or connective tissues. Virus was detected in the
al., 1995a). BH3479 had an ic LD50 of 0.4 PFU and an ip spleens of mice infected with BH3479 at 3 days pi, indica-
LD50 of 0.5 PFU; BHv1 had an ic LD50 of 1.0 PFU and an tive of hematogenous spread; spleen titers reached104
ip LD50 of 106 PFU. A comparison of virulence was PFU/g at 4 days pi (data not shown). Virus was no longer
made using fp inoculation of mice of the same age. Foot- detectable in the spleen from 8 days pi (data not shown).
pad LD50 values for BH3479 were 1.8 PFU and for BHv1 BH3479 was detected in the olfactory lobes of the CNS
were 106 PFU and were virtually identical to ip LD50 at 4 days pi, 24 hr before its appearance in the rest of the
values in 21-day-old Swiss mice. As the outcome of infec- brain (Fig. 1A). Virus entered the cerebral hemispheres at
tion was similar after ip or fp inoculation, fp inoculation 5 days pi and peaked (3 1 109 PFU/g) between 6 and 9
was used in the ensuing studies as it more closely mod- days pi; virus titers in the olfactory lobes and in the rest
els natural infection with MVE. of the brain were essentially identical between 6 and 9
days pi. BH3479-infected mice developed clinically ap-Tissue distribution of BH3479 and BHv1 after footpad
parent encephalitis at 6 days pi and no mice survivedinoculation
for longer than 9 days pi.
Tissue distribution of BHv1. For mice infected withThe low neuroinvasiveness of BHv1 may be due to
reduced virus replication and spread in peripheral tis- BHv1 (Fig. 1B), virus was not detected in lymph nodes
at any time after inoculation (detection threshold, 500sues and/or reduced capacity to cross the blood – brain
barrier and enter the CNS. To explore these possibilities, PFU/g). Viremia was first noted at 72 hr pi and reached
8 1 103 PFU/ml at 96 hr pi. BHv1 was detected in thegroups of fifty 21-day-old Swiss mice were inoculated
into the right hind fp with 100 PFU of BH3479 or BHv1. inoculated footpad (103 PFU/g) at 4 days pi, suggesting
hematogenous spread, and remained detectable until 9Tissues from 3 mice were dissected and processed for
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FIG. 1. Growth of MVE in the tissues of 21-day-old Swiss mice after inoculation of the right hind footpad with 100 PFU of BH3479 or BHv1
(Materials and Methods). Tissues and sera were titrated individually by plaque formation on Vero cells; for each time period tissue titers are the
averages of three mice, which varied less than fourfold. Threshold titers for individual tissues are given in Materials and Methods. (A) BH3479-
infected mice; (B) BHv1-infected mice. Right popliteal lymph node, s; left popliteal lymph node, l; serum, h; right hind limb, j; brain, m; olfactory
lobes, n.
days pi. BHv1 was first noted both in the olfactory lobes tected (1:20) at 4 days pi and peaked between 5 and 6
days pi (1:80). For mice infected with BH3479, anti-MVEand in the rest of the brain at 7 days pi (Fig. 1B); however,
the olfactory lobe titers (2 1 107 PFU/g) were 200-fold IgG was first detected at 6 days pi (1:40) and peaked
at 9 days pi (1:1280). For mice infected with BHv1, IgGgreater than in the rest of the brain (9 1 104 PFU/g) at
this time. By 9 days pi, BHv1 titers were similar (107 antibodies were first detected at 6 days pi (1:20) and
peaked at 14 days pi (1:1280).PFU/g) in both parts of the brain. BHv1 had been cleared
from the CNS by 10 days pi and virus infectivity was not For both groups of mice, there was a clear association
between the time of appearance of anti-MVE IgM anddetected in any host tissues between 10 and 56 days pi.
Compared with BH3479, BHv1 viremia was delayed by
36 hr and reached 20-fold lower titers, and virus entry
TABLE 1into the CNS was delayed by 3 days and at 300-fold lower
titers. Approximately 5% of BHv1-infected mice showed Serum Anti-MVE Antibody Titers of 21-Day-Old Swiss Mice
Infected with BH3479 or BHv1signs of encephalitis (hunching, ruffled fur, asocial be-
havior) at 9 days pi, but most of these mice had recovered
IgMa IgGaby 10 days pi; the mortality rate in BHv1-infected mice
was less than 1%. Mice which recovered from BHv1 in- Days pi BH3479b BHv1 BH3479b BHv1
fection were observed for a total of 8 weeks pi and
3 ndc nd nd ndshowed no clinical evidence of neurological sequelae.
4 20 20 nd nd
5 40 20 nd ndSerum antibody responses of BH3479-
6 40 40 40 20and BHv1-infected mice 7 40 40 160 80
8 40 40 640 160To determine whether humoral immune responses
9 40 40 1280 240
were associated with clearance of BHv1 from host tis- 10 40 320
sues, serum antibody titers to MVE were assayed by 11 40 320
12 40 640ELISA. Serum samples were collected daily between 3
14 40 1280and 14 days pi from groups of three mice infected with
either BH3479 or BHv1. For each sampling time, sera a Antibody titer is the reciprocal of the highest dilution with OD 0.1
were pooled and assayed for anti-MVE IgG and for IgM in ELISA.
(Table 1). b No BH3479-infected mice survived for longer than 9 days pi.
c Anti-MVE antibody not detected.For both groups of mice, anti-MVE IgM was first de-
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the first significant fall in the level of viremia (between 3 not shown). BHv1 RNA was first noted in the gray matter
of the olfactory lobes (within the mitral and granular celland 4 days pi). The anti-MVE IgG response to BHv1 infec-
tion appeared to be associated with clearance of infec- layers) at 7 days pi and was present in the anterior olfac-
tory nuclei, tuberculum olfactorium, and pyriform cerebraltious virus from the CNS.
cortex between 8 and 9 days pi. BHv1 did not spread
further in the CNS after 9 days, but viral RNA remainedDistribution of viral RNA within infected mouse brain
detectable by in situ hybridization until 18 days pi (data
not shown).BH3479 infectivity was observed in the olfactory lobes
of the CNS 24 hr earlier than detection of infectious virus
in the rest of the brain. When BHv1 was first detected in DISCUSSION
the CNS, the titer in olfactory lobes was 200-fold
greater than in the rest of the brain. These data suggest In this study we have compared the growth and tissue
distribution of a highly neuroinvasive field isolate of MVEthat MVE enters the CNS via the olfactory pathway. To
test this hypothesis, a study of the distribution of MVE (BH3479) and a neutralization escape variant (BHv1) of
low neuroinvasiveness, after subcutaneous inoculationRNA in the CNS at increasing time intervals after inocula-
tion was undertaken. The brains and spinal cords of two of the hind limb footpad of weanling Swiss mice. These
viruses differ by a single amino acid at residue 277 inMVE-infected mice were dissected between 3 and 8 days
pi for BH3479 and at 6– 10, 18, and 21 days pi for BHv1. the E protein (McMinn et al., 1995a). The first tissue in
which BH3479 was detected in significant quantity wasFrozen sagittal sections (15 mm) of brain, and transverse
sections of spinal cord (10 mm), were cut on a cryostat, the popliteal lymph node draining the inoculated footpad
at 24 hr pi, after which virus was sequentially detectedfixed for 30 min in 4% paraformaldehyde, and examined
by in situ hybridization using a DIG-labeled MVE E gene in serum (between 36 and 60 hr pi) and within the CNS
(between 4 and 9 days pi). BH3479-infected mice devel-RNA probe (Materials and Methods). Controls included
mock-infected brain sections hybridized with the MVE oped fatal encephalitis between 6 and 9 days pi (100%
mortality). In contrast, BHv1 was not detected in lymphprobe and sections of BH3479- or BHv1-infected brains
hybridized with a Barmah Forest virus E2 gene DIG-la- nodes at any time after inoculation and elicited a delayed
(by 24 hr) and diminished (20-fold lower) viremia andbeled RNA probe of similar length to the MVE probe (data
not shown). delayed (by 3 days) and diminished (300-fold lower) repli-
cation in the CNS compared to BH3479. The mortalityThe first evidence for the presence of BH3479-specific,
positive sense RNA in the CNS was in the gray matter rate of BHv1-infected mice was less than 1%; recovery
from infection was accompanied by the development ofof the olfactory lobes at 4 days pi (Fig. 2A). MVE RNA
was first observed in the glomeruli and in the mitral and a high-titer serum anti-MVE IgG response. Both viruses
appeared to enter the CNS via the olfactory lobes;granular cell layers of the olfactory lobes. At 5 days pi,
viral RNA was detected in the anterior olfactory nuclei, BH3479 spread throughout the CNS in a rostral to caudal
direction, reaching the lumbosacral spinal cord in 3 to 4tuberculum olfactorium, and pyriform cerebral cortex in
addition to the olfactory lobes. The quantity of BH3479 days. Spread of BHv1 in the CNS was more restricted
than for BH3479.RNA within infected brain cells increased markedly be-
tween 5 and 6 days pi. Viral RNA was found increasingly The yield of plaque-forming BH3479 in the popliteal
lymph nodes at 24 hr pi was at least 100-fold greaterwithin major anatomical structures of the brain between
6 and 7 days pi, including the cerebral cortex, corpus than in the inoculum. As significant quantities of virus
were not detected within inoculated footpad tissues upstriatum, limbic structures (hippocampal gyrus, dentate
gyrus, amygdala), midbrain structures (thalamus, hypo- to the time of peak viremia, it is likely that footpad tissues
were infected by viremic spread. Thus, replication at thethalamus), and in the medulla oblongata (Figs. 2B and
2C). Viral RNA was noted in the gray matter of the spinal inoculation site did not appear to be the major source of
virus in the regional lymph nodes. This suggests that thecord between 7 and 8 days pi (Fig. 2D). Interestingly,
viral RNA was observed in the cerebellum of only one infectious virus within regional lymph nodes at 24 hr pi
had been amplified by replication in lymph node cellsmouse (at 7 days pi), with infection restricted to a small
percentage of Purkinje neurons. MVE RNA was present following spread from the footpad via afferent lymphatics.
In contrast, BHv1 was not detected in lymph nodes atin the cytoplasm of infected CNS cells and appeared to
be confined to neurons (Fig. 2E). No viral RNA-containing any time after inoculation, suggesting reduced tropism
for lymph node cells and decreased ability to replicatecells were observed in white matter areas, ependyma,
choroid plexus, or meninges. within them. It is possible that BHv1 was present in lymph
nodes at a level below the sensitivity of the plaque assaySpread of BHv1 within the CNS occurred after a longer
time interval than for BH3479 and was more restricted (threshold 500 PFU/g), in which case the titer of BHv1
in lymph nodes would be at least 200-fold below that ofin distribution; the hybridization signal intensity in BHv1-
infected brain was much lower than for BH3479 (data BH3479.
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FIG. 2. Localization of MVE BH3479 RNA in the central nervous system of Swiss mice by in situ hybridization. The probe was DIG-labeled MVE
E gene RNA of negative polarity; hybridized probe was detected with anti-DIG/alkaline phosphatase and NBT/X-phosphate. Tissue sections were
counterstained with hematoxylin. (A) Anterior sagittal section of mouse brain at 4 days pi. Infection is confined to the mitral neuron layer (m) and
the granular cell layer (g) of the olfactory lobe. Bar, 75 mm. (B) Anterior sagittal section of mouse brain at 6 days pi. Many infected cells are present
in the cerebral cortex (c), hippocampal gyrus (h), and corpus striatum (s). Bar, 240 mm. (C) Posterior sagittal section of mouse brain at 7 days pi.
Infected cells are found throughout the diencephalon (d) and medulla oblongata (o). Bar, 240 mm. (D) Transverse section of cervical spinal cord at
8 days pi. Infected cells are found throughout the ventral and dorsal horn gray matter; the arrow indicates infected ventral horn motor neurons.
Bar, 75 mm. (E) Sagittal section of mouse brain at 7 days pi at high magnification, showing individual MVE-infected cells within the cerebral cortex
(c). Bar, 15 mm.
Viremia in BHv1-infected mice was delayed by 24 hr and to be a major determinant of neuroinvasion (Malkova and
Frankova, 1959; Huang and Wong, 1963). Thus, the lowreached a 20-fold lower titer than for BH3479, probably due
to decreased replication of virus in lymph node cells. Sev- neuroinvasiveness of BHv1 was probably due to a delayed
low-titer viremia in infected mice, resulting from a reducederal elegant experiments have followed the spread of tick-
borne encephalitis virus (Malkova and Frankova, 1959) and input of virus particles into the bloodstream, in turn due to
inefficient replication of virus in lymph node cells. Conse-the spread of JE (Huang and Wong, 1963) in host tissues
after subcutaneous inoculation and have established the quently, BHv1 entered the CNS 3 days later and reached
a 300-fold lower titer than BH3479; BHv1 was cleared fromsignificant contribution of viral replication in lymph nodes
draining the inoculation site on the development of viremia. the CNS by immune responses before the development of
encephalitis.In turn, the magnitude and duration of viremia were shown
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Neuroinvasion by MVE appears to result from a ‘‘race’’
between the rate and extent of virus replication in host
tissues and the development of immune responses. Im-
mune responses to BH3479 did not prevent fatal enceph-
alitis, despite the presence of high-titer anti-MVE IgG in
the serum (1:1280) at 9 days pi. In contrast, the immune
response to BHv1 appeared to play a significant role in
the prevention of encephalitis and in recovery. Delayed
replication of BHv1 was followed by clearance of virus
from host tissues (including the CNS) at 10 days pi and
was associated with the presence of high-titer anti-MVE
IgG in the serum (1:320). Thus, the ‘‘high neuroinvasive-
ness’’ of BH3479 appears to be due to rapid spread of
virus from regional lymph nodes to the bloodstream and
into the CNS, resulting in encephalitis before the devel-
opment of effective immune responses, whereas the ‘‘low
neuroinvasiveness’’ of BHv1 is due to slower spread of
virus from the bloodstream into the CNS, allowing im-
mune responses to clear virus from host tissues and
prevent the development of clinically apparent encephali-
tis. Several studies have highlighted the critical impor-
tance of antibody in recovery from flavivirus (Reid and
Doherty, 1971; Camenga et al., 1974) or from alphavirus
(Levine et al., 1991) encephalitis in animal models. In
contrast, transfer of immune T cells to infected hosts
does not reduce mortality in flavivirus (Camenga et al.,
1974) or in alphavirus (Levine et al., 1991) encephalitis,
suggesting that cell-mediated immunity is of lesser im-
portance than humoral immunity in recovery from neuro- FIG. 3. Diagram of a sagittal section of mouse brain showing the
mode of spread of MVE within the central nervous system. Virus istropic arbovirus infections.
initially in the olfactory lobes and spreads to the spinal cord in a rostralBoth the tissue distribution study and the in situ hybrid-
to caudal direction. The question mark in the cerebellum indicates thatization (ISH) study provided evidence for the entry of MVE does not consistently infect this structure. aDays postinoculation.
MVE into the murine CNS via the olfactory pathway. The
olfactory pathway is composed of unmyelinated olfactory
neurons which arise in a specialized neuroepithelium relatively common portal of entry into the rodent CNS by
neurotropic arboviruses, as an almost identical model oflining the nasal cavity; the capillary bed underlying the
olfactory neuroepithelium is composed of fenestrated viral spread into the CNS to that of MVE has been re-
ported in Venezuelan equine encephalitis virus-infectedcapillaries, allowing direct access of blood-borne patho-
gens to the olfactory neurons. The axons of olfactory mice after peripheral inoculation (Charles et al., 1995).
Upon entry into the olfactory lobes, BH3479 spreadneurons enter the CNS through perforations in the cribri-
form plate and synapse with cells in the glomeruli of the throughout the CNS in a rostral to caudal direction,
reaching the lumbosacral spinal cord between 7 and 8olfactory lobes (see Greep and Weiss, 1973). An outline
of the spread of BH3479 into the CNS, based on the ISH days pi (Fig. 3). The pattern of MVE spread within the
CNS suggests that virus disseminates throughout thestudy, is presented in Fig. 3. Viral RNA was first detected
within the glomeruli, mitral, and granular cell layers of brain along interconnected neural circuits. BHv1 (E-277,
Ser r Ile) also entered the CNS via the olfactory lobes;the olfactory lobes at 4 days pi. However, attempts to
locate MVE RNA within cells of the olfactory neuroepi- however, entry was much later than for parental virus
and BHv1 did not spread beyond the olfactory lobes.thelium have so far been unsuccessful. Our findings sup-
port those of Monath et al. (1983), who found ultrastruc- The restricted distribution of BHv1 within the CNS after
peripheral inoculation is probably due to delayed entrytural evidence of SLE entry into the CNS of Syrian ham-
sters via the olfactory neuroepithelium and olfactory into the CNS and clearance of virus by host immune
responses, as viral growth rates, percentage mortalities,nerve. We conclude that the most likely route of entry of
encephalitogenic flaviviruses into the rodent CNS is by and average survival times were almost identical in
BHv1- and BH3479-infected mice after ic inoculationretrograde spread along olfactory nerve fibers following
infection of the olfactory neuroepithelium from the blood- (P. C. McMinn, unpublished data), indicating that BHv1
is equally capable of growth and spread within the CNSstream. It appears that the olfactory pathway may be a
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search Council of Australia. P.C.M. was supported by a NH & MRCas is BH3479. MVE infection was confined to cells with
Medical Postgraduate Scholarship.the morphological characteristics of neurons, and there
was no evidence of infection in glial cells, ependyma,
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